Potential Restasis rival falls short in head-to-head study
A dry eye therapy designed to compete with Allergan's Restasis failed to reach its primary endpoint in a head-to-head Phase 2a study, according to data released T...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.